|
US2006154870A1
|
|
Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
|
|
US2006293294A1
|
|
Method for treatment or prevention of androgen deficiency
|
|
FI20050268A0
|
|
Method for recovering lignans from wood
|
|
CA2556089A1
|
|
Method for enhancing the bioavailability of ospemifene
|
|
US2005107327A1
|
|
Method for reducing overproduction of neuropeptide Y in an individual
|
|
FI20041216A0
|
|
A method of treating or preventing an androgen deficiency
|
|
WO2005016905A1
|
|
Improved method for the production of hydroxymatairesinol from wood
|
|
MXPA05013104A
|
|
Method for the treatment or prevention of lower urinary tract symptoms.
|
|
US2005187302A1
|
|
Method for treatment or prevention of osteoporosis in individuals with high bone turnover
|
|
AU2003240922A1
|
|
Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis
|
|
FI20030870A0
|
|
New topics and their use in therapy
|
|
FI20030871A0
|
|
Therapeutically active substances and their use
|
|
WO03020251A1
|
|
Method for enhancing endothelial function in humans
|
|
AU8218201A
|
|
A method for reducing stress-induced overproduction of neuropeptide y in an individual
|
|
CA2419977A1
|
|
A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound
|
|
BR0107845A
|
|
Diagnosis of a person's risk of developing alcoholism
|
